COPD activates bitter taste receptors, the target of asthma treatment

Published Date: 17 Mar 2023

Germany: Activation of bitter taste receptors opens lung pathways, making them potential targets for the treatment of chronic lung diseases...

Read Full News

Latest News

Preterm BPD May Reduce Exercise Capacity at School Age

School-aged children born prematurely with bronchopulmonary dysplasia may have exercise-related limitations compared with healthy term-born peers.

Gossamer Bio Shares Plummet as Lung Disease Drug Fails Late-stage Trial

Gossamer Bio's experimental treatment failed to significantly improve exercise capacity in patients with a rare ⁠lung condition in a late-stage study, knocking the drug...

VALIANT: Verekitug Reduces Average Annual Asthma Flare-Ups in Phase 2 Trial

VALIANT: Verekitug Reduces Average Annual Asthma Flare-Ups in Phase 2 Trial

7 Pulmonology Headlines You Missed in January 2026

7 Pulmonology Headlines You Missed in January 2026

Elevated BDNF Linked to Depressive Symptoms in Patients with Asthma, With Hiroshi Iwamoto, MD, PhD

Elevated BDNF Linked to Depressive Symptoms in Patients with Asthma, With Hiroshi Iwamoto, MD, PhD

COPD Drug Withdrawal Tied to Early Exacerbation, With Alexander Mathioudakis, MD, PhD

COPD Drug Withdrawal Tied to Early Exacerbation, With Alexander Mathioudakis, MD, PhD

Todays Updates

From Pathology to Precision: The Story of Leukemia Therapy

From 19th century ‘white blood’ observations and pathological anatomy to the discovery of BCR-ABL and imatinib, leukemia care evolved from near-certain death to precise, life-extending therapies.

Delaying Pegfilgrastim May Curb Bone Pain in Breast Cancer

Pegfilgrastim helps prevent myelosuppression in women undergoing chemotherapy for breast cancer but can also cause severe bone pain. A new study suggests a simple solution.

Todays Updates

From Pathology to Precision: The Story of Leukemia Therapy

From 19th century ‘white blood’ observations and pathological anatomy to the discovery of BCR-ABL and imatinib, leukemia care evolved from near-certain death to precise, life-extending therapies.

Delaying Pegfilgrastim May Curb Bone Pain in Breast Cancer

Pegfilgrastim helps prevent myelosuppression in women undergoing chemotherapy for breast cancer but can also cause severe bone pain. A new study suggests a simple solution.

Latest News

School-aged children born prematurely with bronchopulmonary dysplasia may have exercise-related limitations compared with healthy term-born peers.

Gossamer Bio's experimental treatment failed to significantly improve exercise capacity in patients with a rare ⁠lung condition in a late-stage study, knocking the drug...

VALIANT: Verekitug Reduces Average Annual Asthma Flare-Ups in Phase 2 Trial

7 Pulmonology Headlines You Missed in January 2026

Elevated BDNF Linked to Depressive Symptoms in Patients with Asthma, With Hiroshi Iwamoto, MD, PhD

COPD Drug Withdrawal Tied to Early Exacerbation, With Alexander Mathioudakis, MD, PhD

News All Time

Additional Phase 2 REVERT IPF Data Shows Greater Fibrosis Reduction With TTI-101

Additional Phase 2 REVERT IPF Data Shows Greater Fibrosis Reduction With TTI-101

5 Pulmonology Headlines You Missed in December 2025

5 Pulmonology Headlines You Missed in December 2025

Q4 2025 Recap: Pulmonology News and Updates

Q4 2025 Recap: Pulmonology News and Updates

Pulmonology in 2025: Year in Review

Pulmonology in 2025: Year in Review

Asthma in 2025: Year in Review

Asthma in 2025: Year in Review

COPD in 2025: Year in Review

COPD in 2025: Year in Review

Characterizing COPD - Lung Cancer Patients, with Joseph Friedberg, MD Joseph Friedberg, MD, Kevin Kunzmann

Friedberg discusses the inconsistent clinical pathways from disease progression to intervention in patients with a pair of highly deadly lung diseases.

Post-NICU PM2.5 Exposure Raises Asthma Risk in Children With Bronchopulmonary Dysplasia

Post-NICU PM2.5 Exposure Raises Asthma Risk in Children With Bronchopulmonary Dysplasia

Asthma Biologic Adherence Shaped by Psychological, Clinical, Systemic Factors

Asthma Biologic Adherence Shaped by Psychological, Clinical, Systemic Factors

FDA Approves Nerandomilast (Jascayd) Tablets for Progressive Pulmonary Fibrosis

FDA Approves Nerandomilast (Jascayd) Tablets for Progressive Pulmonary Fibrosis

Sleep Disorders Linked to Poorer Symptom Control in Severe Asthma

Sleep Disorders Linked to Poorer Symptom Control in Severe Asthma

FDA Approves Depemokimab-ulaa (Exdensur) for Severe Asthma

FDA Approves Depemokimab-ulaa (Exdensur) for Severe Asthma

Getting Through the Door: How COPD, Lung Cancer Screening Remains Minimal

Getting Through the Door: How COPD, Lung Cancer Screening Remains Minimal

Advancing NP and PA Involvement in Pulmonary Care, CHEST Learning Susan Corbridge, PhD, Alanna Kavanugh, MSN, CCRN

Susan Corbridge, PhD, and Alanna Kavannagh, MSN, CCRN, discuss the role of advanced practice providers on the evolving pulmonary and critical care teams during CHEST 2025.

Thunderstorms Linked to Surge in Asthma ER Visits

Thunderstorms Linked to Surge in Asthma ER Visits

House Dust Mite SLIT Tablet Well Tolerated in Children With Allergic Asthma

House Dust Mite SLIT Tablet Well Tolerated in Children With Allergic Asthma

Recommended News For You

FDA Investigating Blood Cancer Risk With Gene Therapy Skysona

In patients with prostate cancer, second-generation antiandrogens may worsen fatigue, falls, and cognitive decline.

Housing aid linked to lower medical financial hardship among US renters with cancer

Classifying childhood brain cancers by immune response may improve diagnostics and treatments

Analysis of NRG trial in limited-stage small cell lung cancer suggests QOL benefit with twice- vs. once-daily radiation

Charles III, King of Kings, is Cancerous.

Maintenance Rituximab Improves Survival in Elderly MRD-Negative MCL Patients.

Recommended Articles For You

Recombinant ADAMTS13: Advancing Prophylaxis in Congenital TTP Management 

The Predictive Power of Targeted Radionuclide Therapy in Advanced Breast Cancer 

Cancer Staging: Updates, Clinical Insights, and Educational Resources for Medical Professionals 

Reshaping the Battlefield Through Tumor Microenvironment Modulation for Cancer Therapy 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Q&A: Nipple-Sparing Mastectomy After Breast Radiation

2.

Vaccine elicits strong immune response in patients with pancreatic and colorectal cancer

3.

What is Mohs micrographic surgery? 8 FAQs about Mohs

4.

Loncastuximab-Rituximab Boosts Response Rates in R/R Follicular Lymphoma

5.

An understudied type of breast cancer poses a lurking threat

1.

Understanding Macrocytosis: Causes, Symptoms, and Treatment Options 

2.

Angina Haemorrhagica Bullosa: What You Need to Know

3.

The Ultimate Guide to Understanding Abiraterone and its Uses in Cancer Treatment 

4.

Anesthetic Techniques and Strategies in Cancer Surgery: Unveiling the Impact on Oncological Outcomes

5.

Understanding Protein C Deficiency: Symptoms, Causes, and Treatment

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial

2.

Navigating the Complexities of Ph Negative ALL - Part VIII

3.

Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma

4.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII

5.

Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot